Masoudi H - Search Results

1

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.

Chiu CG, Masoudi H, Leung S, Voduc DK, Gilks B, Huntsman DG, Wiseman SM. Chiu CG, et al. Among authors: masoudi h. Ann Surg. 2010 Jun;251(6):1107-16. doi: 10.1097/SLA.0b013e3181dbb77e. Ann Surg. 2010. PMID: 20485140

2

beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.

Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K, Nabais S, Lopes C, Machado JC, Seruca R, Carneiro F, Huntsman DG. Suriano G, et al. Among authors: masoudi h. Genes Chromosomes Cancer. 2005 Mar;42(3):238-46. doi: 10.1002/gcc.20135. Genes Chromosomes Cancer. 2005. PMID: 15609344

3

Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.

Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Filipenko D, Huntsman D, Gilks B. Wiseman SM, et al. Among authors: masoudi h. Am J Surg. 2006 May;191(5):581-7. doi: 10.1016/j.amjsurg.2006.02.005. Am J Surg. 2006. PMID: 16647341

4

Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.

Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B. Wiseman SM, et al. Among authors: masoudi h. Ann Surg Oncol. 2007 Feb;14(2):719-29. doi: 10.1245/s10434-006-9178-6. Epub 2006 Nov 10. Ann Surg Oncol. 2007. PMID: 17115102

5

Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.

Wiseman SM, Griffith OL, Deen S, Rajput A, Masoudi H, Gilks B, Goldstein L, Gown A, Jones SJ. Wiseman SM, et al. Among authors: masoudi h. Arch Surg. 2007 Aug;142(8):717-27; discussion 727-9. doi: 10.1001/archsurg.142.8.717. Arch Surg. 2007. PMID: 17709725

6

Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.

Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM. Melck A, et al. Among authors: masoudi h. Ann Surg Oncol. 2007 Dec;14(12):3403-11. doi: 10.1245/s10434-007-9572-8. Epub 2007 Sep 20. Ann Surg Oncol. 2007. PMID: 17882495

7

Clinical utility of type 1 growth factor receptor expression in colon cancer.

Leung SP, Griffith OL, Masoudi H, Gown A, Jones S, Phang T, Wiseman SM. Leung SP, et al. Among authors: masoudi h. Am J Surg. 2008 May;195(5):604-10. doi: 10.1016/j.amjsurg.2007.12.032. Am J Surg. 2008. PMID: 18424279

8

Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.

Wiseman SM, Griffith OL, Melck A, Masoudi H, Gown A, Nabi IR, Jones SJ. Wiseman SM, et al. Among authors: masoudi h. Am J Surg. 2008 May;195(5):667-73; discussion 673. doi: 10.1016/j.amjsurg.2008.01.008. Am J Surg. 2008. PMID: 18424286

9

Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.

Wiseman SM, Melck A, Masoudi H, Ghaidi F, Goldstein L, Gown A, Jones SJ, Griffith OL. Wiseman SM, et al. Among authors: masoudi h. Ann Surg Oncol. 2008 Oct;15(10):2811-26. doi: 10.1245/s10434-008-0034-8. Epub 2008 Jul 9. Ann Surg Oncol. 2008. PMID: 18612701

10

Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, Leung S, Wiseman SM, Nabi IR. Joshi B, et al. Among authors: masoudi h. Cancer Res. 2008 Oct 15;68(20):8210-20. doi: 10.1158/0008-5472.CAN-08-0343. Cancer Res. 2008. PMID: 18922892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters